Response: Antifungal prophylaxis with weekly fluconazole for patients with AIDS

被引：5
|
作者：
Mylonakis, E [1 ]
Flanigan, TP [1 ]
机构：
[1] Brown Univ, Sch Med, Miriam Hosp, Dept Med,Div Clin Immunol, Providence, RI 02906 USA
来源：
CLINICAL INFECTIOUS DISEASES | 1998年 / 27卷 / 06期
关键词：
D O I：
10.1086/515017
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1376 / 1378
页数：3
相关论文
共 50 条
  • [31] The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients
    Scharfstein, JA
    Paltiel, AD
    Freedberg, KA
    MEDICAL DECISION MAKING, 1997, 17 (04) : 373 - 381
  • [32] Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
    Yasushi Hiramatsu
    Yoshinobu Maeda
    Nobuharu Fujii
    Takashi Saito
    Yuichiro Nawa
    Masamichi Hara
    Tomofumi Yano
    Shoji Asakura
    Kazutaka Sunami
    Takayuki Tabayashi
    Akira Miyata
    Ken-ichi Matsuoka
    Katsuji Shinagawa
    Kazuma Ikeda
    Keitaro Matsuo
    Mitsune Tanimoto
    International Journal of Hematology, 2008, 88 : 588 - 595
  • [33] Comparative Analysis Fluconazole Vs. Posaconazole As Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Patients
    Teo, Constance Jeanne
    Koh, Liang Piu
    Sia, Charmaine
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S188 - S188
  • [34] Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
    Hiramatsu, Yasushi
    Maeda, Yoshinobu
    Fujii, Nobuharu
    Saito, Takashi
    Nawa, Yuichiro
    Hara, Masamichi
    Yano, Tomofumi
    Asakura, Shoji
    Sunami, Kazutaka
    Tabayashi, Takayuki
    Miyata, Akira
    Matsuoka, Ken-ichi
    Shinagawa, Katsuji
    Ikeda, Kazuma
    Matsuo, Keitaro
    Tanimoto, Mitsune
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (05) : 588 - 595
  • [35] Micafungin twice weekly as antifungal prophylaxis in paediatric patients at high risk for invasive fungal disease
    Bochennek, K.
    Balan, A.
    Mueller-Scholden, L.
    Becker, M.
    Farowski, F.
    Mueller, C.
    Groll, A. H.
    Lehrnbecher, T.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) : 1527 - 1530
  • [36] PHARMACOKINETICS AND BIOAVAILABILITY OF FLUCONAZOLE IN PATIENTS WITH AIDS
    DEMURIA, D
    FORREST, A
    RICH, J
    SCAVONE, JM
    COHEN, LG
    KAZANJIAN, PH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2187 - 2192
  • [37] TRICHOPHYTON ASTHMA - RESPONSE TO ORAL ANTIFUNGAL THERAPY WITH FLUCONAZOLE
    WARD, GW
    HAYDEN, ML
    ROSE, G
    CALL, R
    PLATTSMILLS, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 226 - 226
  • [38] Antifungal Prophylaxis in Haematological Patients
    Deveci, Burak
    Saba, Rabin
    KLIMIK JOURNAL, 2019, 32 : 163 - 167
  • [39] Antifungal prophylaxis in haematology patients
    de la Camara, R.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 65 - 76
  • [40] Antifungal prophylaxis in neutropenic patients
    Boogaerts, MA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 6 (03) : 149 - 154
12345